(Q79195963)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

M H Braun

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

F Sommer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

G Haupt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

M J Mathers

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

B Reifenrath

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

U H Engelmann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

44

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

588-594

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

The natural history of benign prostatic hyperplasia: what have we learned in the last decade?

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Prostate and sexuality: An overview

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Role of alpha adrenergic receptors in erectile function

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Efficacy and safety of sustained-release alfuzosin 5 mg in patients with benign prostatic hyperplasia. ALGEBI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Sustained-release alfuzosin, finasteride and the combination of both in the treatment of benign prostatic hyperplasia. European ALFIN Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Tamsulosin, a selective alpha 1c-adrenoceptor antagonist: a randomized, controlled trial in patients with benign prostatic 'obstruction' (symptomatic BPH). The European Tamsulosin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

3-year followup of urinary symptoms after transurethral resection of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Mortality, morbidity and complications following transurethral resection of the prostate for benign prostatic hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Transurethral prostatectomy: differential effects of age category and presurgery sexual functioning on postprostatectomy sexual adjustment

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Capsular perforation localization and adenoma size as prognostic indicators of erectile dysfunctional after transurethral prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Two-year follow-up of a prospective randomised trial of electrovaporization versus resection of prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Interstitial laser coagulation in the treatment of benign prostatic hyperplasia using a diode-laser system with temperature feedback.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Interstitial laser prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Transurethral needle ablation (TUNA) of the prostate: a clinical and urodynamic evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: early clinical experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Gonadotropins, testosterone, and the aging male

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Sexual function with advancing age.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

1 reference

7 January 2021

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

The clinical relevance of sex hormone levels and sexual activity in the ageing male

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Age dependent secretion of LH and ACTH in healthy men and patients with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Effect of epristeride on the expression of IGF-1 and TGF-beta receptors in androgen-induced castrated rat prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0302-2838%2803%2900358-0

7 January 2021

10.1016/S0302-2838(03)00358-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14572759%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference